Brand-name drug
Kevzara price, strengths & recalls
Brand of sarilumab (generic)
Pharmacies pay $4,720.68 for 2.28 mL of Kevzara 175 mg/mL, 1.14 mL prefilled syringe this week, and from $4,720.68 to $4,732.32 across its 2 priced strengths and forms.
Brand- Fair cash price
- $5,439.28
- Strengths
- 2
- Makers
- 1
- Updated
- Nov 11
Kevzara price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 175 mg/mL, 1.14 mL auto-injector Brand | $2,075.58 | $4,732.32 / 2.28 mL |
| 175 mg/mL, 1.14 mL prefilled syringe Brand | $2,070.48 | $4,720.68 / 2.28 mL |
Kevzara vs generic sarilumab
There is no generic version of Kevzara on the market yet.
GenericSarilumab pricesSupply status: shortages & recalls
What people paid for Kevzara
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label
The official prescribing information is on DailyMed. Read the label
Approval, patents & generics
- Application
- BLA761037 · Sanofi Synthelabo
- First approved
- May 22, 2017 (9 years ago)
- Latest approved change
- June 10, 2024
- Approved label
- PDF, Jun 12, 2024
- Generic makers
- None on the market
Kevzara questions
How much does kevzara cost without insurance?
Pharmacies pay about $4,720.68 for 2.28 mL of kevzara 175 mg/mL, 1.14 mL prefilled syringe ($2,070.48 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $5,439.28. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Kevzara?
Yes: sarilumab. Compare sarilumab prices.
Is kevzara in shortage?
No shortage is reported for kevzara right now. We check the national shortage list every day.
Has kevzara been recalled?
No recalls are on record for kevzara.
Talk about kevzara
No comments yet. Questions, tips, what worked for you - start the conversation.